In a different study, tetrahydroxycurcumin decreased cell survival and promoted apoptosis in lung and pancreatic cancer cell lines by downregulating EGFR and cyclooxygenase‐2 (COX‐2) (Liu et al. 2024). The gene discussed is EGFR; the disease is pancreatic neoplasm.